Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Maki Arakawa"'
Autor:
Maki Arakawa
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
A curva de transição apresenta um raio de curvatura variando de um valor infinito no fim da tangente até um valor igual ao raio da curva circular no final da curva de transição. Nos projetos rodoviários, o tipo de curva mais utilizado é a clot
Publikováno v:
Journal of Chemical Ecology. 40:1146-1151
Males of the cerambycid beetle Xylotrechus pyrrhoderus release a mixture of (S)-2-hydroxy-3-octanone [(S)-1] and (2S,3S)-2,3-octanediol [(2S,3S)-2] as a sex pheromone that attracts conspecific females. The chemical structures of these pheromone compo
Autor:
Masahiko Ikeuchi, Young-Chang P. Arai, Makota Nishihara, Kikuyo Nishida, Maki Arakawa, Takahiro Ushida, Yoshihiro Yamamoto
Publikováno v:
Pain Physician. :E547-E552
Background: Systemic analgesics would not provide good enough pain relief for some kinds of cancer pain. Metastatic bone pain is characteristic of one of the refractory cancer pains, since the pain is not only nociceptive but also neuropathic. A low-
Autor:
Genya Nishikawa, Kazuro Ikawa, Kayo Ikeda, Kogenta Nakamura, Norifumi Morikawa, Yoshiaki Yamada, Kenji Zennami, Maki Arakawa, Nobuaki Honda
Publikováno v:
Journal of Chemotherapy. 24:32-37
Prostatic hypertrophy patients prophylactically received a 0·5-hour infusion of doripenem (250 or 500 mg) before transurethral resection of the prostate. Doripenem concentrations in plasma and prostate tissue were measured chromatographically, and a
Autor:
Kimihito Kato, Yoshiaki Yamada, Kenji Mitsui, Shigeyuki Aoki, Motoi Tobiume, Remi Katsuda, Masayuki Watanabe, Tomohiro Taki, Takaaki Hasegawa, Yoshiharu Kato, Takahiko Yoshizawa, Nobuaki Honda, Genya Nishikawa, Maki Arakawa, Hiroko Saito, Kogenta Nakamura, Kenji Zennami
Publikováno v:
Experimental and Therapeutic Medicine. 2:901-905
The aim of this study was to investigate the relationship between tissue concentrations and exposure times or therapeutic effect of an anthracycline anticancer drug, pirarubicin, in bladder cancer tissue after single intravesical administration again
Publikováno v:
Palliative Care Research. 3:308-315
前立腺がんでは骨転移を併発する. 骨痛が増強し疼痛コントロールを目的として入院となった前立腺がん患者に対し, 骨痛改善のためのビスフォスフォネート製剤であるゾレドロネート(
Autor:
Akiko Kinoshita, Miki Kondo, Chiharu Suzuki, Tatsunori Ikemoto, Young-Chang P. Arai, Maki Arakawa, Makoto Nishihara, Kazuyo Kambara, Yoshihiro Yamamoto
Publikováno v:
Pain medicine (Malden, Mass.). 16(5)
Objective Metastatic bone pain is characteristic of cancer pain and is a form of refractory cancer pain, as the pain includes not only nociceptive but also neuropathic pain. Although some drugs are effective in the management of painful bone metastas
Autor:
Maki, Arakawa-Todo, Takahiko, Yoshizawa, Kenji, Zennami, Genya, Nishikawa, Yoshiharu, Kato, Ikuo, Kobayashi, Keishi, Kajikawa, Yoshiaki, Yamada, Katsuhiko, Matsuura, Ikuto, Tsukiyama, Hiroko, Saito, Takaaki, Hasegawa, Kogenta, Nakamura, Makoto, Sumitomo
Publikováno v:
Anticancer research. 33(11)
Patients with progressive renal cell carcinoma who undergo sunitinib treatment, experience many adverse events (AEs), including thrombopenia and hypertension. Dose reduction or treatment discontinuation due to AEs makes it difficult to control the cl
Autor:
Maki, Arakawa-Todo, Jun, Ueyama, Hiroshi, Nomura, Fumie, Abe, Ikuto, Tsukiyama, Katsuhiko, Matsuura, Takaaki, Hasegawa
Publikováno v:
Anticancer research. 33(8)
The present study investigated the effect of the H2 antagonist cimetidine on the pharmacokinetics of a multi-targeted receptor tyrosine kinase (RTK) inhibitor, sunitinib, in Sprague-Dawley (SD) rats and Eisai hyperbilirubinemic mutant rats (EHBR) lac
Autor:
Inbou Kyoku, Remi Katsuda, Hiroshi Noguchi, Nobuaki Honda, Maki Arakawa, Yoshiaki Yamada, Takaaki Hasegawa, Hiroko Saito, Yasusuke Inoue, Kogenta Nakamura, Kouji Hara, Kenji Zennami, Shigeyuki Aoki, Tomohiro Taki, Katsuya Naruse, Noriko Mitsutake, Motoi Tobiume
Publikováno v:
Molecular medicine reports. 1(6)
Cyclooxygenase-2 (COX-2) activity is reported to increase apoptosis, inhibit angiogenesis and reduce metastasis. We analyzed COX-2 expression in patients with invasive bladder cancer to evaluate the feasibility of selective COX-2 inhibitor treatment